Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
24-25
pubmed:dateCreated
2007-6-4
pubmed:abstractText
The cholinergic control over inflammatory reactions calls for deciphering the corresponding protein partners. An example is blood-nerve barrier disruption allowing penetration of inflammatory factors, which is notably involved in various neuropathies due to yet unknown molecular mechanism(s). In rats, lipopolysaccharide (LPS) administration followed by intra-neural (i.n.) saline injection inducing a focal blood-nerve disruption leads to systemic inflammatory reaction accompanied by transient conduction impairment in the sciatic nerve. Here, we provide evidence compatible with the hypothesis that ARP, the naturally cleavable C-terminal peptide of the stress-induced "readthrough" acetylcholinesterase variant (AChE-R), is causally involved in the emergence of this LPS-induced conduction impairment. Intra-neural injection to naïve rats of conditioned medium from cultured splenocytes exposed to LPS in vitro (reactive splenocyte medium) induced a transient conduction impairment that was accompanied by facilitated accumulation of cleaved intra-neural ARP. Protein kinase C (PKC) betaII, known to interact with ARP, was significantly elevated in the LPS-exposed sciatic nerve preparations. Moreover, direct i.n. injection of synthetic ARP30, bearing the mouse AChE-R C-terminal sequence, similarly induced PKCbetaII expression and conduction impairment. The induction of neural conduction impairment by ARP, possibly through its interaction with PKCbetaII, suggests a role for AChE-R expression in inflammation-associated neuropathies.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
0024-3205
pubmed:author
pubmed:issnType
Print
pubmed:day
30
pubmed:volume
80
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2369-74
pubmed:meshHeading
pubmed-meshheading:17379257-Acetylcholine, pubmed-meshheading:17379257-Acetylcholinesterase, pubmed-meshheading:17379257-Action Potentials, pubmed-meshheading:17379257-Amino Acid Sequence, pubmed-meshheading:17379257-Animals, pubmed-meshheading:17379257-Catalysis, pubmed-meshheading:17379257-Cells, Cultured, pubmed-meshheading:17379257-Culture Media, Conditioned, pubmed-meshheading:17379257-Female, pubmed-meshheading:17379257-Immunoblotting, pubmed-meshheading:17379257-Inflammation, pubmed-meshheading:17379257-Lipopolysaccharides, pubmed-meshheading:17379257-Models, Biological, pubmed-meshheading:17379257-Molecular Sequence Data, pubmed-meshheading:17379257-Muscles, pubmed-meshheading:17379257-Peptide Fragments, pubmed-meshheading:17379257-Peripheral Nervous System Diseases, pubmed-meshheading:17379257-Rats, pubmed-meshheading:17379257-Rats, Inbred Lew, pubmed-meshheading:17379257-Receptors, Cholinergic, pubmed-meshheading:17379257-Sciatic Nerve, pubmed-meshheading:17379257-Spleen
pubmed:year
2007
pubmed:articleTitle
Readthrough acetylcholinesterase in inflammation-associated neuropathies.
pubmed:affiliation
Department of Neurology, The Joseph Sagol Neuroscience Center, Chaim Sheba Medical Center, Tel-Hashomer 52621, Israel.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't